Levey DL - Search Results

1

Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.

SenGupta D, Norris PJ, Suscovich TJ, Hassan-Zahraee M, Moffett HF, Trocha A, Draenert R, Goulder PJ, Binder RJ, Levey DL, Walker BD, Srivastava PK, Brander C. SenGupta D, et al. Among authors: levey dl. J Immunol. 2004 Aug 1;173(3):1987-93. doi: 10.4049/jimmunol.173.3.1987. J Immunol. 2004. PMID: 15265933

2

The potential of heat shock protein-peptide complexes as a therapeutic HIV vaccine.

Levey DL, Brander C, Srivastava PK. Levey DL, et al. J HIV Ther. 2005 Sep;10(3):56-9. J HIV Ther. 2005. PMID: 16385973

3

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.

Udono H, Levey DL, Srivastava PK. Udono H, et al. Among authors: levey dl. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3077-81. doi: 10.1073/pnas.91.8.3077. Proc Natl Acad Sci U S A. 1994. PMID: 7909157 Free PMC article.

4

Alterations in T cells of cancer-bearers: whence specificity?

Levey DL, Srivastava PK. Levey DL, et al. Immunol Today. 1996 Aug;17(8):365-8. doi: 10.1016/0167-5699(96)10013-X. Immunol Today. 1996. PMID: 8783496 Review.

5

High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses.

Flechtner JB, Cohane KP, Mehta S, Slusarewicz P, Leonard AK, Barber BH, Levey DL, Andjelic S. Flechtner JB, et al. Among authors: levey dl. J Immunol. 2006 Jul 15;177(2):1017-27. doi: 10.4049/jimmunol.177.2.1017. J Immunol. 2006. PMID: 16818758

6

A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.

Mo A, Musselli C, Chen H, Pappas J, Leclair K, Liu A, Chicz RM, Truneh A, Monks S, Levey DL, Srivastava PK. Mo A, et al. Among authors: levey dl. Vaccine. 2011 Nov 3;29(47):8530-41. doi: 10.1016/j.vaccine.2011.07.011. Epub 2011 Jul 19. Vaccine. 2011. PMID: 21767588

7

T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.

Levey DL, Srivastava PK. Levey DL, et al. J Exp Med. 1995 Oct 1;182(4):1029-36. doi: 10.1084/jem.182.4.1029. J Exp Med. 1995. PMID: 7561676 Free PMC article.

8

Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons.

Wald A, Koelle DM, Fife K, Warren T, Leclair K, Chicz RM, Monks S, Levey DL, Musselli C, Srivastava PK. Wald A, et al. Among authors: levey dl. Vaccine. 2011 Nov 3;29(47):8520-9. doi: 10.1016/j.vaccine.2011.09.046. Epub 2011 Sep 21. Vaccine. 2011. PMID: 21945262 Clinical Trial.

9

Identification of a tumor-associated contact-dependent activity which reversibly downregulates cytolytic function of CD8+ T cells.

Levey DL, Udono H, Heike M, Srivastava PK. Levey DL, et al. Cancer Immun. 2001 Mar 30;1:5. Cancer Immun. 2001. PMID: 12747766

10

Autologous heat shock protein-peptide complexes for vaccination against cancer: from bench to bedside.

Hoos A, Levey DL, Lewis JJ. Hoos A, et al. Among authors: levey dl. Dev Biol (Basel). 2004;116:109-15; discussion 133-43. Dev Biol (Basel). 2004. PMID: 15603187 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters